Philipp Beckhove

12.8k citations

150 papers · 8.4k indexed · 2 hit papers · h-index 45

Immunology top 0.2%
Oncology top 0.2%
Molecular Biology top 5%
Pulmonary and Respiratory Medicine top 5%
Cancer Research top 2%

Co-authors: Volker Schirrmacher Ludmila Umansky Günter J. Hämmerling Natalio Garbi Jürgen Weitz Markus Feuerer Viktor Umansky Florian Schuetz
Topics: Immunotherapy and Immune Responses (78 papers)Cancer Immunotherapy and Biomarkers (50 papers)Immune Cell Function and Interaction (38 papers)
Cited by: Immunology Oncology Genetics
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation Nature Medicine
Partner nations: Germany United States Switzerland

In The Last Decade

Philipp Beckhove

148 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy

2013 840 citations Tobias Seibel, Niels Halama et al. profile →
Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells

2015 380 citations Philipp Beckhove et al. profile →

Peers

Countries citing papers authored by Philipp Beckhove

Since Specialization

Citations

This map shows the geographic impact of Philipp Beckhove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Beckhove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Beckhove more than expected).

Fields of papers citing papers by Philipp Beckhove

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Beckhove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Beckhove. The network helps show where Philipp Beckhove may publish in the future.

Co-authorship network of co-authors of Philipp Beckhove

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Beckhove. A scholar is included among the top collaborators of Philipp Beckhove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Beckhove. Philipp Beckhove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype 2023 ·Cells ·Frank Braun,(unknown),Julia Lorenz,Sandra Pohl,Ayse N. Menevse,Arabel Vollmann‐Zwerenz,Elisabeth Bumes,Maren Büttner,Saida Zoubaa,Martin Proescholdt,Nils Ole Schmidt,Peter Hau,Philipp Beckhove,Beate Winner,Markus J. Riemenschneider	8
2	The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients 2020 ·Cancer Letters ·Gerrit Spanier,(unknown),(unknown),(unknown),Sandra Schmidhofer,Almut Brand,Johannes K. Meier,Steffen Spoerl,Rosemarie Krupar,Petra Rümmele,Peter J. Siska,Kathrin Renner,Katrin Peter,Michael Gerken,Philipp Beckhove,Torsten E. Reichert,Marina Kreutz,Katrin Singer	9
3	Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer 2019 ·Cancer Immunology Research ·Yingzi Ge,(unknown),Anchana Rathinasamy,(unknown),Xiaoying Hu,(unknown),Ludmila Umansky,(unknown),(unknown),Andreas Bonertz,Alexandra Sevko,Christoph Domschke,Florian Schuetz,Helge Frebel,Steffen Dettling,Christel Herold‐Mende,Christoph Reißfelder,Jürgen Weitz,Viktor Umansky,Philipp Beckhove	22
4	Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma 2018 ·Clinical Cancer Research ·Steffen Dettling,Slava Stamova,Rolf Warta,Martina Schnölzer,Carmen Rapp,Anchana Rathinasamy,David Reuß,(unknown),Saskia Roesch,Christine Jungk,Uwe Warnken,Volker Eckstein,Niels Grabe,Christoph Schramm,Markus Weigand,Andreas von Deimling,Andreas Unterberg,Philipp Beckhove,Christel Herold‐Mende	22
5	Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses 2018 ·OncoImmunology ·Jasmin Quandt,(unknown),Michael Bartoschek,Rainer Will,Ángel Cid-Arregui,Sebastian Schölch,Christoph Reißfelder,Jürgen Weitz,Martin Schneider,Stefan Wiemann,Frank Momburg,Philipp Beckhove	35
6	A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer 2017 ·OncoImmunology ·Friedrich H. Schmitz-Winnenthal,Nicolas Hohmann,Thomas Schmidt,(unknown),(unknown),Heinz Lubenau,(unknown),Sébastien Wieckowski,Klaus M. Breiner,Gerd Mikus,Markus W. Büchler,(unknown),(unknown),Christoph Springfeld,Phillip Knebel,Mariana Bucur,Lars Grenacher,Walter E. Haefeli,Philipp Beckhove	60
7	Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab 2015 ·Clinical Cancer Research ·Christoffer Gebhardt,Alexandra Sevko,Huanhuan Jiang,Ramtin Lichtenberger,Maike Reith,Kathrin Tarnanidis,Tim Holland‐Letz,Ludmila Umansky,Philipp Beckhove,Antje Sucker,Dirk Schadendorf,Jochen Utikal,Viktor Umansky	290
8	Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis 2014 ·Journal of Clinical Investigation ·Christoph Reißfelder,Slava Stamova,(unknown),Marion Braun,Andreas Bonertz,(unknown),(unknown),Nuh N. Rahbari,Moritz Koch,Maral Saadati,Axel Benner,Markus W. Büchler,Dirk Jäger,Niels Halama,Khashayarsha Khazaie,Jürgen Weitz,Philipp Beckhove	119
9	PI3K/AKT Signaling Is Essential for Communication between Tissue-Infiltrating Mast Cells, Macrophages, and Epithelial Cells in Colitis-Induced Cancer 2013 ·Clinical Cancer Research ·Mohammad W. Khan,Ali Keshavarzian,Elias Gounaris,Joshua Melson,Eric C. Cheon,Nichole R. Blatner,(unknown),(unknown),Goo Lee,Hyunji Ryu,Terrence A. Barrett,David J. Bentrem,Philipp Beckhove,Khashayarsha Khazaie	63
10	Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy 2011 ·Cancer Research ·Niels Halama,Sara Michel,Matthias Kloor,Inka Zoernig,Axel Benner,Anna Spille,Thora Pommerencke,(unknown),Gunnar Folprecht,Birgit Luber,(unknown),Uwe M. Martens,Philipp Beckhove,Sacha Gnjatic,Peter Schirmacher,Esther Herpel,Juergen Weitz,Niels Grabe,Dirk Jaeger	321
11	Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β 2011 ·Clinical Cancer Research ·Jennifer Lohr,(unknown),Andrea Huppertz,Yingzi Ge,Christine Dictus,Rezvan Ahmadi,Stefan Grau,Nobuyoshi Hiraoka,Volker Eckstein,Rupert Ecker,Thomas Korff,Andreas von Deimling,Andreas Unterberg,Philipp Beckhove,Christel Herold‐Mende	272
12	CD40L co‐stimulation from CD8 ⁺ to CD4 ⁺ effector memory T cells supports CD4 ⁺ expansion 2010 ·Immunology and Cell Biology ·(unknown),Yingzi Ge,(unknown),Philipp Beckhove	9
13	Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells 2010 ·Clinical Cancer Research ·Benito Campos,Feng Wan,Mohammad Farhadi,Aurélie Ernst,Felix Zeppernick,Katrin E. Tagscherer,Rezvan Ahmadi,Jennifer Lohr,Christine Dictus,Georg Gdynia,Stephanie E. Combs,Violaine Goidts,Burkhard Helmke,Volker Eckstein,Wilfried Roth,Philipp Beckhove,Peter Lichter,Andreas Unterberg,Bernhard Radlwimmer,Christel Herold‐Mende	251
14	T-Regulatory Cells Shift from a Protective Anti-Inflammatory to a Cancer-Promoting Proinflammatory Phenotype in Polyposis 2009 ·Cancer Research ·Elias Gounaris,Nichole R. Blatner,Kristen L. Dennis,Fay Magnusson,Michael F. Gurish,Terry B. Strom,Philipp Beckhove,Fotini Gounari,Khashayarsha Khazaie	156
15	Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer–Specific Immune Responses and Their Correlation to Prognosis 2009 ·Cancer Research ·Christoph Domschke,Florian Schuetz,Yingzi Ge,Tobias Seibel,Christine S. Falk,Benedikt Brors,Israël Vlodavsky,Nora Sommerfeldt,Hans‐Peter Sinn,(unknown),Andreas Schneeweiß,Alexander Scharf,Christof Sohn,Volker Schirrmacher,Gerhard Moldenhauer,Frank Momburg,Philipp Beckhove	47
16	Chronic Pancreatitis Is Associated With Disease-Specific Regulatory T-Cell Responses 2009 ·Gastroenterology ·Hubertus Schmitz‐Winnenthal,(unknown),Simon Schimmack,Andreas Bonertz,(unknown),Yingzi Ge,Luis Javier Galindo,(unknown),Christine Volk,Kaspar Z’graggen,Moritz Koch,Markus W. Büchler,Jürgen Weitz,Philipp Beckhove	44
17	The Shaping of a Polyvalent and Highly Individual T-Cell Repertoire in the Bone Marrow of Breast Cancer Patients 2006 ·Cancer Research ·Nora Sommerfeldt,Florian Schütz,(unknown),(unknown),Volker Schirrmacher,Philipp Beckhove	49
18	High Frequencies of Functional Tumor-Reactive T Cells in Bone Marrow and Blood of Pancreatic Cancer Patients 2005 ·Cancer Research ·Friedrich H. Schmitz-Winnenthal,Christine Volk,Kaspar Z’graggen,Luis Javier Galindo,Daniel Nummer,(unknown),(unknown),Jürgen Weitz,Volker Schirrmacher,Markus W. Büchler,Philipp Beckhove	127
19	Dynamic Differentiation of Activated Human Peripheral Blood CD8+ and CD4+ Effector Memory T Cells 2005 ·The Journal of Immunology ·Jochen Schwendemann,Carmen Choi,Volker Schirrmacher,Philipp Beckhove	44
20	Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors 2004 ·Journal of Clinical Investigation ·Philipp Beckhove,Markus Feuerer,(unknown),Florian Schuetz,Carmen Choi,Nora Sommerfeldt,Jochen Schwendemann,(unknown),Peter Altevogt,G. Bastert,Volker Schirrmacher,Viktor Umansky	103

About Philipp Beckhove

Philipp Beckhove is a scholar working on Immunology, Oncology and Biotechnology, having authored 150 papers that have together received 8.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (78 papers), Cancer Immunotherapy and Biomarkers (50 papers) and Immune Cell Function and Interaction (38 papers). The work is most often cited by research in Immunology (5.0k citations), Oncology (4.8k citations) and Genetics (568 citations). Philipp Beckhove has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Volker Schirrmacher, Ludmila Umansky, Günter J. Hämmerling, Natalio Garbi, Jürgen Weitz, Markus Feuerer, Viktor Umansky, Florian Schuetz, Christel Herold‐Mende and Peter E. Huber. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact